Intriguingly, the stromal expression of the HMGA2 protein independently predicts poorer clinical outcomes in pancreatic cancer and ampullary adenocarcinoma patients [90], indicating that parallel chromatin remodeling processes by HMGA2 occur in both tumoral and stromal compartments of cancers. The gene discussed is HMGA2; the disease is pancreatic neoplasm.